Chemours Company (NYSE:CC): A Bullish Investment Perspective
We came across a long thesis on Chemours Company (NYSE:CC) on ValueInvestorsClub by Glory_Warriors. In this article we will summarize the bulls’ thesis on CC.
Chemours Co (CC)
Market is closed
Sector: Chemicals & Allied Products
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Bourgeon Capital John Zaro | 44,000 | $743,600 | -13% | 0.13% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $32.63 | 7,661 | Officer, Director | 266,955 | 2023-06-09 | Filing | |
| $34.63 | 7,661 | Officer, Director | 266,955 | 2023-06-09 | Filing | |
| $11.62 | 1,000 | Officer | 133,344 | 2020-05-07 | Filing | |
| $11.62 | 1,500 | Officer | 132,344 | 2020-05-07 | Filing | |
| $10.15 | 11,000 | Officer | 141,891 | 2020-03-13 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $20.64 | 7,500 | Officer | 16,645 | 2024-11-07 | Filing | |
| $18.84 | 1,108 | Officer | 19,890 | 2024-08-07 | Filing | |
| $18.81 | 1,576 | Officer | 20,998 | 2024-08-07 | Filing | |
| $19.04 | 73 | Officer | 22,574 | 2024-08-06 | Filing | |
| $32.30 | 5,125 | Officer | 13,890 | 2023-06-09 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 16,512,174 | $520,793,963 | 0.01% | |
| 2. | 16,443,589 | $518,630,818 | 0.03% | |
| 3. | 16,028,054 | $505,524,823 | 0.01% | |
| 4. | 5,787,225 | $182,529,051 | 0.03% | |
| 5. | 4,763,368 | $150,236,627 | 0.04% |
News See All
Here’s Buckley Capital’s Updates on Chemours (CC)
Buckley Capital Advisors, an investment management company, released its third quarter 2024 investor letter. A copy of the letter can be downloaded here.
The Chemours Company (NYSE:CC) Q3 2024 Earnings Call Transcript
Operator: Good morning. My name is Daniel and I will be your conference operator today. I would like to welcome everyone to The Chemours Company Third Quarter 2024 Results Conference Call.
10 Worst Specialty Chemical Stocks to Buy According to Short Sellers
Companies in the specialty chemicals sector produce value-added specialty chemicals that play an essential role across a wide range of industries.
The Chemours Company (NYSE:CC) Q2 2024 Earnings Call Transcript
Operator: Good morning. My name is Regina and I will be your conference operator today. I’d like to welcome everyone to the Chemours Company's Second Quarter 2024 Results Conference Call.
The Chemours Company (NYSE:CC) Q1 2024 Earnings Call Transcript
Operator: Good morning. My name is Lovely, and I will be your conference operator today. I would like to welcome everyone to The Chemours Company First Quarter 2024 Results Conference Call.
The Chemours Company (NYSE:CC) Q3 2023 Earnings Call Transcript
Operator: Good morning. My name is Rob, and I will be your conference operator today. At this time, I would like to welcome everyone to The Chemours Company Third Quarter 2023 Results Conference Call.
Madison Small Cap Fund Exited The Chemours Company (CC) on Strength
Madison Investments, an investment advisor, released its “Madison Small Cap Fund” third-quarter 2023 investor letter. A copy of the same can be downloaded here.
The Chemours Company (NYSE:CC) Q2 2023 Earnings Call Transcript
Operator: Good morning. My name is Jeannie, and I will be your conference operator today. At this time, I would like to welcome everyone to The Chemours Company Second Quarter Earnings Call.
The Chemours Company (NYSE:CC) Q1 2023 Earnings Call Transcript
Operator: Good morning, and welcome to the Chemours Company First Quarter 2023 Earnings Call. As a reminder, this conference call is being recorded.
Billionaire Hedge Funds
